← Open Payments lookup

MICHAEL WILLIAMS: Open Payments

NPI 1295706430 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,542 in 140 payments from 20 companies in 2025. Trend: 2023 $2,534 · 2024 $2,689 · 2025 $2,542

Food & beverage: $2,537Education: $5
CompanyPaymentsAmount
ABBVIE INC.30$489
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)24$465
Teva Pharmaceuticals USA, Inc.21$275
Janssen Pharmaceuticals, Inc17$250
Vanda Pharmaceuticals Inc.7$177
E.R. Squibb & Sons, L.L.C.8$151
Otsuka America Pharmaceutical, Inc.5$108
Axsome Therapeutics, Inc.5$95
Lundbeck LLC3$81
Neurocrine BioSciences, Inc.4$77

Products named: VRAYLAR, CAPLYTA, AUSTEDO XR, REXULTI, FANAPT, SPRAVATO, COBENFY, INVEGA SUSTENNA.

Industry payments across MO — which companies pay providers there.